Brighter Side of News
HomeGood NewsDiscoveriesInnovationsGlobal GoodHealthGreen ImpactSpaceAICelebritiesGNISubscribe

Tirzepatide

Weight-loss drug Tirzepatide significantly slows breast cancer growth, study finds

New study shows weight-loss drug tirzepatide slows breast cancer growth in obese mice, offering hope for dual-action treatment.

Joshua Shavit
First head-to-head trial compares tirzepatide and semaglutide – Results are in!Joshua Shavit
New drug tirzepatide delivers significant and long-lasting weight lossJoshua Shavit
Obesity drugs show heart health benefits beyond weight lossRebecca Shavit
Lifechanging FDA approved drug results in over 50 pound weight lossJoseph Shavit
FDA-approved drug averages over 50 pound weight lossJoseph Shavit
New FDA approved drug results in 50+ pound weight lossJoseph Shavit
Lifechanging FDA approved drug results in 50+ pound weight lossJoseph Shavit
FDA approves new drug resulting in 50+ pound weight lossJoseph Shavit
People lost over 50 pounds by taking new FDA-approved pillJoseph Shavit
Brighter Side of News
  • Explore
  • About Us
  • News Feed
  • Sitemap
  • Editorial Guidelines
  • Legal
  • Privacy
  • Terms
  • Read More
  • Newsletter Sign-up
  • Flipboard